ARCHIVES

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002

NCI Programs to Average Eight Percent Increase Over ’87 Under House Total, Bit Some Would Vary

August 14, 1987

Mysterious Group Urges Letters In Support Of Fisher, Calls For Investigation of NCI

April 22, 1994

Colorado Researchers Study Massage To Reduce Symptoms

September 26, 2003

NCI’s Weinstein Said He Never Pressured Researcher

November 3, 1995

U of Pittsburgh Wins NCI Grant To Include End-of-Life Issues In Med. School Curriculum.

July 6, 2001